SCHEMBL3747032

SCHEMBL3747032

CC(N[S+]([O-])C(C)(C)C)c1cc(-c2ccccc2)n(C)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 5/20 0.34
P2RY1 P47900 1/20 0.34
ATP1A1 P05023 6/20 0.33
ATP1B1 P05026 6/20 0.33
ATP1A3 P13637 6/20 0.33
ATP1B2 P14415 6/20 0.33
ATP1A2 P50993 6/20 0.33
ATP1B3 P54709 6/20 0.33
FXYD2 P54710 6/20 0.33
ATP1A4 Q13733 6/20 0.33
GRM5 P41594 1/20 0.33
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
STAT3 P40763 1/20 0.32
MME P08473 1/20 0.31
MAPK14 Q16539 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
NR1H4 Q96RI1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13041057 1.00 PHGDH (0.34) PHGDHP2RY1ATP1A1ATP1B1ATP1A3
SCHEMBL19259714 0.88 PTGS2 (0.33) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL19259715 0.88 PTGS2 (0.33) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL27755636 0.76 P2RY1 (0.35) PHGDHP2RY1ATP1A1ATP1B1ATP1A3
SCHEMBL16386822 0.75 DDB1 (0.42) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL20558944 0.73 MAP4K4 (0.38)
SCHEMBL20558946 0.73 MAP4K4 (0.38)
SCHEMBL19034289 0.73 RAB9A (0.40)
SCHEMBL20558940 0.73 MAP4K4 (0.38)
SCHEMBL16088972 0.73 RAB9A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES C1R, C3AR1, PTH1R PHGDH 2235/4885P2RY1 1582/4885ATP1A1 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.